Price: $ 1295
BMI View: The government's promise to improve healthcare conditions through rising expenditure will bring potential growth to pharmaceutical firms over the longer term. However, we highlight that there may be a risk of not fulfilling such aims, given extensive bureaucracy and rampant corruption. In addition, the macroeconomic condition was less -than optimistic between Q1 and Q2 this year. Should this continue, it will be challenging for the country to invest in healthcare substantially. Headline Expenditure Projections ? Pharmaceuticals: VND59,214bn (US$2.84bn) in 2012 to VND69,455bn (US$3.32bn) in 2013; +17.3% in local currency terms and +17.1% in US dollar terms. Forecast broadly unchanged from Q313. ? Healthcare: VND201,466bn (US$9.66bn) in 2012 to VND232,015bn (US$11.1bn) in 2013; +15.2 ...
Complete report details with Table of Contents and more @ http://www.marketreportsonline.com/285063.html
No comments:
Post a Comment